The ITA reports that a sample collected from Ujah Chijindu, sprinter from Great Britain, has returned an Adverse Analytical Finding for Ostarine and SARMS S-23.
— International Testing Agency (@IntTestAgency) August 12, 2021
➡️ https://t.co/AonXzU5qMn#KeepingSportReal pic.twitter.com/vN2qrK8FI6